Compound details
(+)-Buxabenzamidienine
| Compound ID | CDAMM02654 |
|---|---|
| Common name | (+)-Buxabenzamidienine | IUPAC name | N-[15-[1-(dimethylamino)ethyl]-7,7,12,16-tetramethyl-6-tetracyclo[9.7.0.03,8.012,16]octadeca-1(18),2-dienyl]benzamide |
| Molecular formula | C33H48N2O |
| Retention time | 13.15 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 489.386 | Theoretical mz | 489.384 |
| Error | 3.73 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.4584 |
| Inchi key | PDEYVCIISSAEBG-UECJVQBINA-N |
|---|---|
| Smiles | O=C(NC1CCC2=CC3=CCC4(C)C(CCC4(C)C3CCC2C1(C)C)C(N(C)C)C)C=5C=CC=CC5 |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q9Y5N1 | HRH3 | Histamine H3 receptor | T64765 | SwissTargetPrediction |
| P22303 | ACHE | Acetylcholinesterase | T30082 | SwissTargetPrediction |
| Q02083 | NAAA | N-acylsphingosine-amidohydrolase (by homology) | T78326 | SwissTargetPrediction |
| P21731 | TBXA2R | Thromboxane A2 receptor | T76198 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| Q92847 | GHSR | Ghrelin receptor | T59604 | SwissTargetPrediction |
| Q13258 | PTGDR | Prostanoid DP receptor | T68782 | SwissTargetPrediction |
| Q16602 | CALCRL | Calcitonin gene-related peptide type 1 receptor | T02226 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T64765 | DI0392 | Somnolence | [ICD-11: MG42] | Q9Y5N1 | HRH3 |
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T76198 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P21731 | TBXA2R |
| T76198 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P21731 | TBXA2R |
| T76198 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P21731 | TBXA2R |
| T76198 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P21731 | TBXA2R |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T59604 | DI0087 | Chronic pain | [ICD-11: MG30] | Q92847 | GHSR |
| T59604 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | Q92847 | GHSR |
| T68782 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q13258 | PTGDR |